Q2 2016 Holdings
Filed 2016-08-12 | 82 holdings | $459.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Lilly ELI & Co(LLY) | COM | 532457108 | $47.4M | 601,800 | 10.3% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $46.2M | 1,103,300 | 10.1% |
| Abbott Labs(ABT) | COM | 002824100 | $30.6M | 778,900 | 6.7% |
| Shire PLC | SPONSORED ADR | 82481R106 | $30.0M | 163,200 | 6.5% |
| Biogen Inc(BIIB) | COM | 09062X103 | $24.6M | 101,600 | 5.4% |
| Amgen Inc(AMGN) | COM | 031162100 | $23.7M | 155,932 | 5.2% |
| Healthways Inc | COM | 422245100 | $21.1M | 1,827,829 | 4.6% |
| Aetna Inc New | COM | 00817Y108 | $19.9M | 162,700 | 4.3% |
| Anthem Inc(ELV) | COM | 036752103 | $18.9M | 143,800 | 4.1% |
| Universal Hlth Svcs Inc(UHS) | CL B | 913903100 | $15.4M | 114,700 | 3.4% |
| Centene Corp del(CNC) | COM | 15135B101 | $12.3M | 172,800 | 2.7% |
| Laboratory Corp Amer Hldgs | COM NEW | 50540R409 | $11.3M | 86,800 | 2.5% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $10.6M | 482,000 | 2.3% |
| Endologix Inc | COM | 29266S106 | $10.1M | 809,800 | 2.2% |
| Acorda Therapeutics Inc | COM | 00484M106 | $9.1M | 358,191 | 2.0% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $9.0M | 800,788 | 2.0% |
| Momenta Pharmaceuticals Inc(MNTA) | COM | 60877T100 | $8.7M | 808,198 | 1.9% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $8.5M | 339,070 | 1.8% |
| Tesaro Inc | COM | 881569107 | $7.9M | 94,300 | 1.7% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $7.8M | 788,936 | 1.7% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $7.5M | 150,700 | 1.6% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $6.8M | 785,744 | 1.5% |
| Corium Intl Inc | COM | 21887L107 | $6.0M | 1,736,466 | 1.3% |
| Retrophin Inc | COM | 761299106 | $5.9M | 329,489 | 1.3% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $5.7M | 102,400 | 1.2% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $5.6M | 144,624 | 1.2% |
| K2m Group Hldgs Inc | COM | 48273J107 | $5.5M | 356,300 | 1.2% |
| Tandem Diabetes Care Inc | COM | 875372104 | $4.6M | 615,311 | 1.0% |
| Syneron Medical LTD | ORD SHS | M87245102 | $3.9M | 510,240 | 0.9% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $3.8M | 598,397 | 0.8% |
| Valeant Pharmaceuticals Intl | COM | 91911K102 | $3.3M | 165,400 | 0.7% |
| Inotek Pharmaceuticals Corp | COM | 45780V102 | $3.3M | 445,022 | 0.7% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $3.2M | 1,443,003 | 0.7% |
| Arena Pharmaceuticals Inc | COM | 040047102 | $3.2M | 1,872,191 | 0.7% |
| Neuroderm LTD | ORD SHS | M74231107 | $3.2M | 195,800 | 0.7% |
| Aviragen Therapeutics Inc | COM | 053761102 | $2.8M | 2,034,576 | 0.6% |
| Tokai Pharmaceuticals Inc | COM | 88907J107 | $2.8M | 511,010 | 0.6% |
| Agile Therapeutics Inc(AGRXUSD) | COM | 00847L100 | $2.7M | 361,199 | 0.6% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $2.2M | 219,743 | 0.5% |
| Paratek Pharmaceuticals Inc | COM | 699374302 | $1.9M | 134,219 | 0.4% |
| Zogenix Inc | COM NEW | 98978L204 | $1.7M | 214,900 | 0.4% |